These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 159050)

  • 1. Correlation between the toxicity of platinum drugs to L1210 leukaemia cells and their mutagenic properties.
    Lecointe P; Macquet JP; Butour JL
    Biochem Biophys Res Commun; 1979 Sep; 90(1):209-13. PubMed ID: 159050
    [No Abstract]   [Full Text] [Related]  

  • 2. DNA crosslinking induced by 1,2-diaminocyclohexanedichloroplatinum(II) in murine leukemia L1210 cells and comparison with other platinum analogues.
    Strandberg MC; Bresnick E; Eastman A
    Biochim Biophys Acta; 1982 Aug; 698(2):128-33. PubMed ID: 6889887
    [No Abstract]   [Full Text] [Related]  

  • 3. Roasting coffee beans produces compounds that induce prophage lambda in E. coli and are mutagenic in E. coli and S. typhimurium.
    Kosugi A; Nagao M; Suwa Y; Wakabayashi K; Sugimura T
    Mutat Res; 1983 Mar; 116(3-4):179-84. PubMed ID: 6220221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological activity of benzylating N-nitroso compounds. Models of activated N-nitrosomethylbenzylamine.
    Wiessler M; Romruen K; Pool BL
    Carcinogenesis; 1983; 4(7):867-71. PubMed ID: 6223716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenic activity of nitrosourea antitumor agents.
    Franza BR; Oeschger NS; Oeschger MP; Schein PS
    J Natl Cancer Inst; 1980 Jul; 65(1):149-54. PubMed ID: 6446611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of DNA replication in carrier-ligand-specific resistance to platinum compounds in L1210 cells.
    Gibbons GR; Kaufmann WK; Chaney SG
    Carcinogenesis; 1991 Dec; 12(12):2253-7. PubMed ID: 1747924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, mutagenicity, binding to pBR 322 DNA and antitumour activity of platinum(II) complexes with ethambutol.
    Coluccia M; Fanizzi FP; Giannini G; Giordano D; Intini FP; Lacidogna G; Loseto F; Mariggio MA; Nassi A; Natile G
    Anticancer Res; 1991; 11(1):281-7. PubMed ID: 2018362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platinum complexes with anticancer potential and their evaluation by a colorimetric lambda prophage induction assay.
    Das Sarma B; Daley SK; Elespuru RK
    Chem Biol Interact; 1983 Sep; 46(2):219-32. PubMed ID: 6226378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mutagenic and carcinogenic actions of some polycyclic aromatic hydrocarbons].
    Linnik AB; Tolcheev IuD; Khitrova IA
    Biull Eksp Biol Med; 1979 Nov; 88(11):592-5. PubMed ID: 395973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity consideration of novel anticancer platinum pyrimidine "greens".
    Shimura T; Tomohiro T; Maruno K; Fujimoto Y; Okuno Y
    Chem Pharm Bull (Tokyo); 1987 Dec; 35(12):5028-31. PubMed ID: 3451821
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of mutagenicity, antitumor activity, and chemical properties of selected nitrosoureas and nitrosoamides.
    Brundrett RB; Colvin M; White EH; McKee J; Hartman PE; Brown DL
    Cancer Res; 1979 Apr; 39(4):1328-33. PubMed ID: 421216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative mutagenic activity and toxicity of triethylphosphate and dichlorvos in bacteria and Drosophila.
    Dyer KF; Hanna PJ
    Mutat Res; 1973 Jun; 21(3):175-7. PubMed ID: 4200711
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumours.
    Goddard PM; Orr RM; Valenti MR; Barnard CF; Murrer BA; Kelland LR; Harrap KR
    Anticancer Res; 1996; 16(1):33-8. PubMed ID: 8615631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of novel ammine/amine platinum (IV) dicarboxylates in L1210 murine leukaemia cells sensitive and resistant to cisplatin, tetraplatin or carboplatin.
    Orr RM; O'Neill CF; Nicolson MC; Barnard CF; Murrer BA; Giandomenico CM; Vollano JF; Harrap KR
    Br J Cancer; 1994 Sep; 70(3):415-20. PubMed ID: 8080724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenicity of aclacinomycin A and daunomycin derivatives.
    Umezawa K; Sawamura M; Matsushima T; Sugimura T
    Cancer Res; 1978 Jun; 38(6):1782-4. PubMed ID: 348304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential antitumor agents. 33. Quantitative structure--activity relationships for mutagenic activity and antitumor activity of substituted 4'-(9-acridinylamino)methanesulfonanilide derivatives.
    Ferguson LR; Denny WA
    J Med Chem; 1980 Mar; 23(3):269-74. PubMed ID: 6988589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenicity for Salmonella typhimurium of urine obtained from humans receiving nitrofurantoin.
    Wang CY; Benson RC; Bryan GT
    J Natl Cancer Inst; 1977 Apr; 58(4):871-3. PubMed ID: 321796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutagenic activity of radiosensitizers.
    Grzybowska E; Kalinowska E; Szala S
    Acta Microbiol Pol; 1985; 34(2):111-20. PubMed ID: 2412398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mutagenic action of platinum and palladium compounds on bacteria].
    Suraĭkina TI; Zakharova IA; Mashkovskiĭ IuSh; Fonshteĭn LM
    Tsitol Genet; 1979; 13(6):486-91. PubMed ID: 399702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re: Effects of bidentate malonate ligand on the utilization and cytotoxicity of platinum compounds in the L1210 cell line.
    Wyrick SD; Chaney SG
    Cancer Res; 1987 Sep; 47(18):4992. PubMed ID: 3621186
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.